Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $43 at UBS
Tweet Send to a Friend
UBS analyst Ashwani Verma lowered the price target on Harmony Biosciences Holdings Inc. (NASDAQ: HRMY) to $43.00 (from $50.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
